Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Joerg O. Schwab"'
Autor:
Yusuke Kondo, MD, PhD, Marehiko Ueda, MD, PhD, Yoshio Kobayashi, MD, PhD, Joerg O. Schwab, MD, PhD
Publikováno v:
Journal of Arrhythmia, Vol 32, Iss 4, Pp 297-302 (2016)
There has been a significant increase in the number of patients receiving cardiovascular implantable electronic devices (CIED) over the last two decades. CIED infection represents a serious complication after CIED implantation and is associated with
Externí odkaz:
https://doaj.org/article/37975d48783c46cb80cd409ca1428124
Autor:
Yusuke Kondo, M.D., Ph.D., Markus Linhart, M.D., René P. Andrié, M.D., Joerg O. Schwab, M.D., Ph.D.
Publikováno v:
Journal of Arrhythmia, Vol 31, Iss 5, Pp 293-295 (2015)
Background: The effectiveness of the wearable cardioverter defibrillator (WCD) therapy in early post-myocardial infarction (MI) patients remains uncertain. Methods: We analyzed the characteristics and outcomes of patients who received a WCD in the ea
Externí odkaz:
https://doaj.org/article/95a679409d8d45d9a72fc8754317b1bf
Autor:
Takatsugu Kajiyama, Kazuo Miyazawa, Joerg O. Schwab, Masahiro Nakano, Yusuke Kondo, Masayuki Inagaki, Yoshio Kobayashi, Samuel F. Sears, Marehiko Ueda
Publikováno v:
Pacing and Clinical Electrophysiology. 41:1171-1177
Background Patient-reported outcomes of implantable cardioverter defibrillator (ICD), such as those with shock anxiety, have emerged as important endpoints that are related to quality of life (QOL), but they have not been well studied in a sample of
Autor:
Joerg O. Schwab
Publikováno v:
Journal of JCS Cardiologists. 25:45-48
Autor:
Kazuo, Miyazawa, Yusuke, Kondo, Marehiko, Ueda, Takatsugu, Kajiyama, Masahiro, Nakano, Masayuki, Inagaki, Joerg O, Schwab, Samuel F, Sears, Yoshio, Kobayashi
Publikováno v:
Pacing and clinical electrophysiology : PACE. 41(9)
Patient-reported outcomes of implantable cardioverter defibrillator (ICD), such as those with shock anxiety, have emerged as important endpoints that are related to quality of life (QOL), but they have not been well studied in a sample of the Japanes
Autor:
Wolfgang R. Bauer, Andreas Lang, Hanno Oswald, Tino Hauser, Joerg O. Schwab, Paul Korb, Oliver Gunkel, Herbert Nägele, Gunnar Klein
Publikováno v:
BioMed Research International, Vol 2018 (2018)
BioMed Research International
BioMed Research International
Patients receiving dual-chamber implantable cardioverter-defibrillator (DR-ICD) therapy are at risk of developing atrial arrhythmia because of the increased rate of ventricular pacing and the progression of heart failure. Remote monitoring (RM) may i
Autor:
Juergen Gieseke, Hans H. Schild, Christian Stehning, Alois M. Sprinkart, Claas P. Naehle, Rolf Fimmers, Darius Dabir, Rami Homsi, Daniel Thomas, Jonas Doerner, Julian A. Luetkens, Joerg O. Schwab
Publikováno v:
Radiology. 273:383-392
To evaluate the diagnostic value of cardiac magnetic resonance (MR) imaging at 3 T in patients suspected of having acute myocarditis by using a multiparametric cardiac MR imaging approach including T1 relaxation time as an additional tool for tissue
Publikováno v:
Journal of Arrhythmia, Vol 31, Iss 5, Pp 293-295 (2015)
Background: The effectiveness of the wearable cardioverter defibrillator (WCD) therapy in early post-myocardial infarction (MI) patients remains uncertain. Methods: We analyzed the characteristics and outcomes of patients who received a WCD in the ea
Autor:
Fritz Mellert, Felix Hoyer, Georg Nickenig, Jens Kreuz, Fritz Horlbeck, Joerg O. Schwab, Rolf Fimmers, Lars Lickfett
Publikováno v:
Pacing and Clinical Electrophysiology. 34:894-899
Background: This study investigated the overall mortality and the incidence of ventricular tachyarrhythmia (VT) in 99 patients with nonischemic cardiomyopathy (NICM) and with an implantable cardioverter defibrillator (ICD) suffering from heart failur
Autor:
Joerg O. Schwab
Publikováno v:
Fundamental & Clinical Pharmacology. 24:653-659
With the increasing numbers of patients with implantable cardioverter/defibrillators for primary prevention (PP), the topic of inappropriate therapy becomes more and more important. If a shock intervention, e.g. for rapidly conducted atrial fibrillat